Latest Breaking News On - Vivo chairman - Page 1 : comparemela.com

Vivos Therapeutics highlights path to cash flow positivity after FDA clearance

Vivos Therapeutics highlights path to cash flow positivity after FDA clearance
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesEast north africaKirk huntsmanVivos institute in denverDrug administrationVivos therapeuticsVivos integrated providerVivos instituteDemand orthodontistMiddle east north africaVivo chairmanChief executive officer

Vivos Therapeutics, Inc (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript

Vivos Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-3.05 EPS, expectations were $-1.9.

United statesScott henryKirk huntsmanJulie gannonVivos therapeutics incDrug administrationExchange commissionVivos instituteVivos therapeuticsCall transcript marchVivos therapeutics fourth quarterFull yearInvestor relationsVivo investor relations officerVivo chairmanChief executive officer

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited arab emiratesEast north africaKirk huntsmanJulie gannonSecurities exchangeDrug administrationEnvista holdings corporationAirway repositioningVivos institute in denverVivos therapeutics incExchange commissionPositive business momentumSales pipeline growth followingVivo proprietary oral medical devicesTreat severe obstructive sleep

Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark Clear Aligners to Its National Network of Providers

04.10.2023 - New Relationships Expected to Add Potentially Significant New Revenue Opportunities for Vivos as well as Airway-Focused Expertise and Potential Cost Savings for Vivos-trained ProvidersLITTLETON, Colo., Oct. 04, 2023 (GLOBE NEWSWIRE) - Vivos . Seite 1

Kirk huntsmanEnvista holdings corporationVivo chairmanChief executive officerClear alignersSpark alignersDemand orthodontistVivos therapeutics chartIvos therapeutics kursIvos therapeutics aktie

Vivos Therapeutics In Deals With Ormco, On Demand Orthodontist; Stock Up In Pre-market

Medical device and technology company Vivos Therapeutics, Inc. (VVOS) announced Wednesday two key strategic agreements with Ormco, a division of Envista Holdings Corp.

Kirk huntsmanVivos therapeutics incEnvista holdings corpVivos therapeuticsEnvista holdingsDemand orthodontistSpark clearVivo chairmanChief executive officerSpark alignersMedical deviceVivos therapeuticsSpark clear aligner